Background Most clinical measurements of radioactivity, whether for therapeutic or imaging nuclides, rely on commercial re-entrant ionization chambers ('dose calibrators'). The National Institute of Standards and Technology (NIST) maintains a battery of representative calibrators and works to link calibration settings ('dial settings') to primary radioactivity standards. Here, we provide a summary of NIST-determined dial settings for 22 radionuclides.
Introduction
Activity measurements in the radiopharmaceutical industry rely almost exclusively on commercial re-entrant ionization chambers referred to variously as 'radionuclide calibrators', 'activimeters', or 'dose calibrators'. These devices, consisting of a pressurized ionization chamber and an electrometer, typically provide a readout directly in activity units, relying on a specific calibration setting or 'dial setting' (DS) to convert measured current to displayed activity. In 2000, Zimmerman and Cessna [1] reported on the methodology and results of experiments at the National Institute of Standards and Technology (NIST) to determine DSs for 11 radionuclides commonly used in nuclear medicine applications. In this paper, we update those results to include new imaging and therapeutic radionuclides. We provide appropriate references, where available, and briefly describe the measurements where the determinations are otherwise unpublished.
Materials and methods
In most cases, DS determinations are carried out using the calibration curve method [1] . A source is measured at a series of DSs covering a range that includes the setting that returns the true activity. One advantage of this method is that it can be employed before a precision assay of the radioactive source as long as an approximate activity can be determined to select an appropriate range of DSs for the curve. Another advantage is that this method makes it easier to evaluate uncertainties as the SE of the fit (calculated from the residuals of the fit to the calibration curve) provides a good estimate for the uncertainty because of the method and the sensitivity to small changes in DS. This approach also allows the uncertainty to be expressed in terms of both DS units and activity.
Uncertainties on determined DSs or, analogously, on the activities measured with them, are typically mostly due to the uncertainty on the primary standard. Primary activity measurements are performed at NIST using a variety of techniques, among which coincidence counting [2, 3] and liquid scintillation-based efficiency tracing or triple-todouble coincidence ratio counting [4, 5] are most common. For radionuclides detected with high counting efficiency and relatively simple decay schemes, total combined uncertainties, determined using the methodology outlined by Taylor and Kuyatt [6] , of~0.5% are often achievable. With these standards, a dose calibrator can typically be calibrated to allow activity measurements with expanded (k = 2) uncertainties of~1%. In most cases, the settings reported here match those given in the previous NIST summary [1] . The very notable exception is for 18 F. The settings reported here supplant the earlier ones, reflecting the revised NIST standard [7, 20] Sm has been updated on the basis of new measurements, but differs only slightly from the previous report.
Results and discussion
In most cases, new DS determinations have been described in the literature. The few exceptions are addressed here: 
Ho 1991 [14] 16 ml In 20 ml glass dose vial
Ho 1991 [14] 10 ml Plastic dose vial
Re 2000 [15] Ace glass v-vial, 0.96-2.12 g
Re 2000 [15] Wheaton v-vials,
In November 2017, a standard NIST 5-ml flame-sealed ampoule containing 5 g of solution was obtained from the NIST Radioactivity Measurement Assurance Program (NRMAP) [21] and measured on multiple dose calibrators. The standard activity was taken from secondary standard ionization chamber measurements on NIST chamber 'A' (ICA) (Centronic, 20th Century Electronics Ltd., Croydon, UK) [22] using the calibration factor ('K-value') determined in 1976 [23] . The primary standardization used coincidence counting with a custom pressurized proportional counter/ NaI(Tl) system. The uncertainty on the standard activity (0.44%) was the largest component in the combined standard uncertainties on the DSs.
The manufacturer-recommended DS (80) for the Capintec (Ramsey, New Jersey, USA) CRC-15R and CRC-35R chambers resulted in activity readings biased by + 1.6 and + 1.9%, respectively [24] . The recommended DS (37.1) for the AtomLab-400 and AtomLab-500 chambers (Sun Nuclear, Shirley, New York, USA) resulted in readings biased by − 1.6 and − 2.1%, respectively [25] . (Although each calibrator has its own manual, the DS tables are consistent across the Capintec R series and across the Biodex AtomLab series. We cite just one manual from each manufacturer).
Source geometry sensitivity in dose calibrator measurements of 99m
Tc has been discussed previously [26] and in the study by Zimmerman and Cessna [1] DSs for the CRC-12 were given for the ampoule and 10 ml Mallinckrodt dose vial geometries (Mallinckrodt Pharmaceuticals, St. Louis, Missouri, USA). Those values are presented in Table 1 . Significantly, the new values presented for the CRC-15R and CRC-35R are consistent with the previous DS found for the CRC-12.
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In September 2012, four ampoules from the NRMAP were measured on multiple dose calibrators. The standard activity was taken from ICA using the K-value determined in 1977. The primary standardization used coincidence counting with a pressurized proportional counter/NaI(Tl) system. The uncertainty on the standard activity (0.55%) was the largest component in the total combined uncertainties on the DSs.
The manufacturer-recommended DS (303) for the CRC-12, CRC-15R, and CRC-35R chambers [24] resulted in activity readings biased by + 3.2, + 3.4, and + 2.4%, respectively.
153
Sm
In July and August 2013, an ampoule from the NRMAP was measured on multiple dose calibrators. The standard activity was taken from ICA using the K-value determined in 1985. The primary standardization used 4πβ liquid scintillation counting. The primary standard had a fairly large uncertainty (≈2%) and a large correction (≈1.5%) for the geometric drift in ICA [27] was required; a new primary standardization for this nuclide is desirable. The uncertainty on the standard activity (≈2%) was the largest contributor to the combined standard uncertainties on the DSs. The calibration factors with their expanded (k = 2) uncertainties are given in bold for each specific radionuclide and geometry. The standard geometry, denoted simply as 'ampoule' in the table, is the NIST 5 ml flame-sealed ampoule containing 5 ml of radioactive solution. Below each calibration factor, the % uncertainty on the measured activity that results from the expanded uncertainty on the calibration factor (U A /%) is given. The year of the NIST primary standardization upon which the DS determination is based is given, along with the reference describing the DS determination, where available. In some cases, the DS is given with a multiplier, for example, '57 (2) × 10', indicating that the reading using DS = 57 should be multiplied by 10 to give the correct activity; in this example the expanded uncertainty on the DS is 2DS units. The value and accompanying uncertainty reported here are the average and SD of two determinations performed on solutions with different compositions. c Also see the study by Zimmerman et al. [19] for volume effects and v-vial geometries. The DSs reported here were determined by the 'dialing-in' method [1] , where the DS is tuned to give the correct activity. Uncertainties are estimated as equivalent to the uncertainty on the activity determined with the contemporaneously-determined K VIC . e The primary standard has a 2% combined standard uncertainty; Zimmerman and Cessna found DS = 252 for the CRC-12 chamber in 2000 [1] . f This DS was also found to be valid for a 10R Schott vial. Eu responses at the 153 Sm DS were not known. Over time, the effect of ingrowing impurities on DS bias was evident. To reduce bias, DS determinations relied on the earliest data acquired, where they appeared stable to less than 0.1%. The large uncertainties due to the standard activity and height correction dwarf any residual biases or underestimate of the total combined standard uncertainties. 177 
Lu
In 2012, NIST participated in a comparison of clinical dose calibrator measurements of 177 Lu piloted by the NPL [29] . The source was delivered in a 10 ml Schott-type dose vial and NIST performed measurements on multiple dose calibrators in both the dose vial and 5 ml ampoule geometries. The standard activity was taken from ICA using the K-value determined in 2009 by anticoincidence counting [30] . The uncertainty on the standard activity (0.37%) was the largest component in the combined standard uncertainties on the determined DSs in all cases except for the CRC-35R calibrator, where the uncertainty on the reading (estimated in this case from the range of minimum and maximum readings observed over a few seconds) was larger.
In general, the results were in good agreement with the manufacturer's recommendations, with previous NISTdetermined DSs [31] , and with the NPL.
Discussion
Ionization chamber calibrations are an integral part of primary activity standardization efforts at NIST. For the short-lived radionuclides of interest in nuclear medicine especially, calibrated ionization chambers establish an enduring means of assaying new samples with traceability to the primary activity standard. As secondary standard ionization chambers like the Vinten 671 Ionization Chamber establish indirect links with other metrology institutes around the world, dose calibrators link NIST standards to clinical and industrial measurements -with some caveats.
NIST always recommends that DS determinations be considered valid only for the specific calibrators and source characteristics described. Users should verify the results on their own systems. This is especially important when environmental conditions (e.g. backgrounds and local shielding) may significantly differ from those at NIST. Using the NIST methods rather than the NIST results also ensures against any larger than expected calibrator-to-calibrator variation.
In addition to suggesting that users verify all calibrations on their own instruments, NIST stresses the importance of regular quality control measurements (see user's manuals), especially measurements of a long-lived source to monitor response constancy. Long-term trending in constancy measurements or abrupt deviations from the expected response requires investigation. At best, a change in response, perhaps owing to a change in the local environment (e.g. addition of shielding) indicates that new calibration verifications are required. A change in response that cannot be explained by a change in the local environment may indicate instrument failure (e.g. damage to the electronics or a loss of chamber pressure), requiring that the calibrator be removed from service.
Another important consideration involves the practice of 'sharing' calibrations between instruments. This practice is common when a user maintains multiple calibrators of the same type: one calibration verification on a specific instrument serves to establish a site-specific DS, which is then shared among all instruments. This practice can be dangerous if a DS is shared between instruments from the same manufacturer but from different generations. For example, the Capintec CRC-12, CRC-15R, and CRC-35R calibrators maintained at NIST are designed to give similar responses for a given DS; however, the CRC-25 PET is representative of a different series of instruments designed to handle higher activities for PET applications, and requires a distinct DS. In fact, the CRC-25 PET manual [32] includes DSs for only eight nuclides, half of which were determined with NIST-traceable sources and the other half by intercomparison with a CRC-15R instrument. The validity of a DS should always be tested for each individual calibrator.
Occasionally, updated standards or nuclear data evaluations [8, 17] , result in a change in the DS recommended by instrument manufacturers or pharmaceutical companies. DS changes should only be made in response to specific instructions from pharmaceutical manufacturers, and any discrepancy between a local assay and the activity reported by the manufacturer should be investigated.
Finally, in recent years the use of long-lived calibration surrogates for some radionuclides has become a viable option. The use of 68 Ge sources as surrogates for short-lived PET radionuclides is now firmly established [8, 33] . However, some approaches, such as the use of 133 Ba as a surrogate for 131 I can lead to errors [13] .
Conclusion
NIST has carried out calibrations for 22 radionuclides on different re-entrant ionization chambers ('dose calibrators') and often in multiple geometries. In most cases, calibration factors or 'dial settings' are determined using the calibration curve method. This paper presents a collection of NIST-determined DSs for medically relevant radionuclides, addressing uncertainties and pointing to Dose calibrator settings Bergeron and Cessna 503 relevant references. The DSs are considered applicable for the NIST calibrators and the specifically described geometries; users are encouraged to check their validity on their own systems.
In general, the NIST-determined DSs are consistent with current manufacturer recommendations. This is in contrast to the situation reported in 2000 [1] , when most of the considered manufacturer-provided DSs overestimated activities, in some cases by more than 20%. In general, improved accuracy can be interpreted as reflecting the positive impact of an emphasis on traceability to common measurement standards.
